Due to strong Cresemba sales in Japan, Basilea announced this morning that it had received its first milestone payment from partner Asahi...

PureTech provides investors with diversified exposure to biotechnology in a way few others do. While it is somewhat higher risk than a...

In our research report published this morning , we updated our forecasts and valuation to incorporate the recent funding award from...